ET
TNDM icon

Entropy Technologies’s Tandem Diabetes Care TNDM Stock Holding History

Entropy Technologies’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,951
Closed -$280K – 931
2024
Q2 		$280K Buy
+6,951
New +$290K 0.03% 520

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Entropy Technologies's TNDM Position: Q3 2024 in Review

Entropy Technologies sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 6,951 shares — an estimated $280K sold.

Entropy Technologies first reported a position in TNDM in Q2 2024 and held it in 1 quarter. The position peaked at $280K in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Entropy Technologies reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Entropy Technologies sold 6,951 Tandem Diabetes Care shares in Q3 2024, an estimated $280K.
  • Entropy Technologies first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 1 quarter.
  • Entropy Technologies's Tandem Diabetes Care position peaked at $280K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Entropy Technologies's 13F filing for Q3 2024, filed 4 Nov 2024.